Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 Patients
Clinical trial NCT05132972 · UNKNOWN
Trial details
- NCT number
- NCT05132972
- Sponsor
- Kementerian Riset dan Teknologi / Badan Riset dan Inovasi Nasional, Indonesia
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-17
- Primary completion
- 2021-11-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.